Literature DB >> 14572562

The seroprevalence of Helicobacter pylori in a referral population of children in the United States.

Sonny K F Chong1, Qinyuan Lou, Terrell W Zollinger, Simon Rabinowitz, Rima Jibaly, Vasundhara Tolia, Yoram Elitsur, Benjamin D Gold, Allan Rosenberg, Abiodun Johnson, Orit Elkayam, Philip Rosenthal, Mark Gilger, B U K Li, Jeffrey S Peacock.   

Abstract

OBJECTIVES: The purpose of this study was to determine the prevalence of serum antibodies directed against Helicobacter pylori (H. pylori) in children referred to children's hospitals or medical centers throughout the United States.
METHODS: This multisite cross-sectional prospective study involved 992 children from 12 states using a validated anti-H. pylori IgG enzyme immunoassay. The children were recruited into two groups: those without any GI complaints (non-GI referral, n = 619) and those who were referred for endoscopy because of abdominal pain (GI referral, n = 373).
RESULTS: GI referral children had a higher rate of seropositivity (22.5%) than non-GI referral children (14.1%) from the same geographic regions. In both groups, older children were more likely to be seropositive for H. pylori, as were nonwhite children and those with lower socioeconomic status. H. pylori seropositivity rates were higher in GI referral children with four or more household members (relative risk [RR] = 1.47; CI 1.01-2.14). Multivariate analysis controlling for age, ethnicity, and household income, showed that presence of GI symptoms were associated with a nearly 2-fold risk for H. pylori seropositivity (odds ratio = 1.77, CI 1.27-2.47). Epigastric pain (RR = 2.21; CI = 1.33-3.66) and having three or more episodes of abdominal pain in the last 3 months (RR = 0.59, CI = 0.35-0.99) were the only specific symptoms significantly associated with H. pylori seropositivity.
CONCLUSIONS: The H. pylori seropositivity rate of GI referral children with symptoms of abdominal pain was significantly higher. H. pylori infection in early childhood was found to be associated primarily with the child's household size and socioeconomic status.

Entities:  

Mesh:

Year:  2003        PMID: 14572562     DOI: 10.1111/j.1572-0241.2003.07683.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Helicobacter pylori Detection and Eradication in Pediatric and Adult Patients.

Authors:  Benjamin D Gold; Adam B Elfant
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

2.  Factors associated with H. pylori epidemiology in symptomatic children in Buenos Aires, Argentina.

Authors:  Cinthia Goldman; Andrés Barrado; Mariana Janjetic; Norma Balcarce; Eduardo Cueto Rua; Masaru Oshiro; María L Calcagno; Margarita-Martinez Sarrasague; Julián Fuda; Ricardo Weill; Marcela Zubillaga; Guillermo I Perez-Perez; José Boccio
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Helicobacter pylori serology testing is a useful diagnostic screening tool for symptomatic inner city children.

Authors:  Priya Raj; John F Thompson; Debra H Pan
Journal:  Acta Paediatr       Date:  2017-01-20       Impact factor: 2.299

4.  Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis.

Authors:  Idit Segal; Anthony Otley; Robert Issenman; David Armstrong; Victor Espinosa; Ruth Cawdron; Muhammad G Morshed; Kevan Jacobson
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

5.  Positive association between Helicobacter pylori and gastroesophageal reflux disease in children.

Authors:  Aeri Moon; Aliza Solomon; Debra Beneck; Susanna Cunningham-Rundles
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-09       Impact factor: 2.839

6.  Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.

Authors:  Seyed Mohsen Dehghani; Asma Erjaee; Mohammad Hadi Imanieh; Mahmood Haghighat
Journal:  Dig Dis Sci       Date:  2008-11-14       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.